LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Dovitinib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 1500 | 3769 | 0.3981 | 0.1510 |
BT-20 | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 1097 | 4264 | 3769 | 1.1313 | 1.1852 |
BT-20 | Erlotinib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 3231 | 3769 | 0.8573 | 0.7987 |
BT-20 | Foretinib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 1303 | 3769 | 0.3458 | 0.0772 |
Hs 578T | SU11274 | 0.37 | uM | LJP5 | 72 | hr | 658 | 3698 | 3846 | 0.9616 | 0.9536 |
Hs 578T | Fedratinib | 0.37 | uM | LJP5 | 72 | hr | 658 | 3225 | 3846 | 0.8385 | 0.8052 |
Hs 578T | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 658 | 789 | 3846 | 0.2051 | 0.0410 |
BT-20 | Geldanamycin | 3.33 | uM | LJP5 | 72 | hr | 1097 | 936 | 3769 | 0.2483 | -0.0603 |
BT-20 | WH-4-025 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 2814 | 3769 | 0.7467 | 0.6427 |
BT-20 | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 474 | 3769 | 0.1258 | -0.2331 |
BT-20 | SB590885 | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3918 | 3769 | 1.0395 | 1.0557 |
BT-20 | Sigma A6730 | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3200 | 3769 | 0.8491 | 0.7871 |
BT-20 | XMD16-144 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 1323 | 3769 | 0.3512 | 0.0847 |
BT-20 | GSK 690693 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 2005 | 3769 | 0.5321 | 0.3399 |
BT-20 | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3699 | 3769 | 0.9813 | 0.9736 |
BT-20 | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 1818 | 3769 | 0.4823 | 0.2697 |
BT-20 | Buparlisib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 1950 | 3769 | 0.5175 | 0.3194 |
BT-20 | NU7441 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 3048 | 3769 | 0.8086 | 0.7300 |
BT-20 | BX-912 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3616 | 3769 | 0.9594 | 0.9427 |
BT-20 | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3436 | 3769 | 0.9116 | 0.8753 |
BT-20 | NVP-AEW541 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3912 | 3769 | 1.0378 | 1.0533 |
BT-20 | LDN-193189 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 357 | 3769 | 0.0947 | -0.2770 |
BT-20 | SB590885 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3896 | 3769 | 1.0337 | 1.0476 |
BT-20 | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 3521 | 3769 | 0.9342 | 0.9072 |
Hs 578T | AZD8330 | 1.11 | uM | LJP5 | 72 | hr | 658 | 1003 | 3846 | 0.2608 | 0.1082 |